Clinical trial / 2015
High onion intake lowered cancer markers during doxorubicin chemotherapy
A double-blind trial randomized 56 breast cancer patients receiving doxorubicin into groups consuming 100-160 g/day or 30-40 g/day of fresh yellow onion for eight weeks. Participants consuming the higher amount of onion showed significant reductions in carcinoembryonic antigen, cancer antigen-125, and alkaline phosphatase levels compared to the low-onion group (P < 0.05).
- Study type
- Randomized controlled trial
- Who was studied
- 56 breast cancer patients treated with doxorubicin
- What was measured
- Tumor markers and hepatic enzymes
THE PAPER
Effects of Fresh Yellow Onion Consumption on CEA, CA125 and Hepatic Enzymes in Breast Cancer Patients: A Double- Blind Randomized Controlled Clinical Trial.
Jafarpour-Sadegh F, Montazeri V, Adili A, Esfehani A, Rashidi MR, Mesgari M, Pirouzpanah S. Asian Pac J Cancer Prev, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.